INFU
Price
$9.58
Change
-$0.05 (-0.52%)
Updated
Aug 18, 03:31 PM (EDT)
Capitalization
196.7M
85 days until earnings call
PAVM
Price
$0.43
Change
-$0.02 (-4.44%)
Updated
Aug 18, 03:45 PM (EDT)
Capitalization
7.78M
Interact to see
Advertisement

INFU vs PAVM

Header iconINFU vs PAVM Comparison
Open Charts INFU vs PAVMBanner chart's image
InfuSystem Holdings
Price$9.58
Change-$0.05 (-0.52%)
Volume$300
Capitalization196.7M
PAVmed
Price$0.43
Change-$0.02 (-4.44%)
Volume$400
Capitalization7.78M
INFU vs PAVM Comparison Chart in %
Loading...
INFU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PAVM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INFU vs. PAVM commentary
Aug 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INFU is a Hold and PAVM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 18, 2025
Stock price -- (INFU: $9.63 vs. PAVM: $0.45)
Brand notoriety: INFU and PAVM are both not notable
INFU represents the Pharmaceuticals: Other, while PAVM is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: INFU: 109% vs. PAVM: 67%
Market capitalization -- INFU: $196.7M vs. PAVM: $7.78M
INFU [@Pharmaceuticals: Other] is valued at $196.7M. PAVM’s [@Medical/Nursing Services] market capitalization is $7.78M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $172.16B to $0. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $229.31B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.04B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.55B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INFU’s FA Score shows that 0 FA rating(s) are green whilePAVM’s FA Score has 0 green FA rating(s).

  • INFU’s FA Score: 0 green, 5 red.
  • PAVM’s FA Score: 0 green, 5 red.
According to our system of comparison, INFU is a better buy in the long-term than PAVM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INFU’s TA Score shows that 6 TA indicator(s) are bullish while PAVM’s TA Score has 3 bullish TA indicator(s).

  • INFU’s TA Score: 6 bullish, 4 bearish.
  • PAVM’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, INFU is a better buy in the short-term than PAVM.

Price Growth

INFU (@Pharmaceuticals: Other) experienced а +9.06% price change this week, while PAVM (@Medical/Nursing Services) price change was -1.55% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +1.89%. For the same industry, the average monthly price growth was -0.55%, and the average quarterly price growth was +12.18%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +2.79%. For the same industry, the average monthly price growth was +3.67%, and the average quarterly price growth was +3.54%.

Reported Earning Dates

INFU is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+1.89% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical/Nursing Services (+2.79% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INFU($197M) has a higher market cap than PAVM($7.78M). INFU has higher P/E ratio than PAVM: INFU (40.13) vs PAVM (0.10). INFU YTD gains are higher at: 13.965 vs. PAVM (-28.319). PAVM has higher annual earnings (EBITDA): 66.2M vs. INFU (21.2M). PAVM has more cash in the bank: 2.7M vs. INFU (1.51M). PAVM has less debt than INFU: PAVM (9.24M) vs INFU (33.2M). INFU has higher revenues than PAVM: INFU (138M) vs PAVM (1.99M).
INFUPAVMINFU / PAVM
Capitalization197M7.78M2,532%
EBITDA21.2M66.2M32%
Gain YTD13.965-28.319-49%
P/E Ratio40.130.1039,340%
Revenue138M1.99M6,924%
Total Cash1.51M2.7M56%
Total Debt33.2M9.24M359%
FUNDAMENTALS RATINGS
INFU vs PAVM: Fundamental Ratings
INFU
PAVM
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
71
Overvalued
55
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
82100
PRICE GROWTH RATING
1..100
3692
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
9075

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PAVM's Valuation (55) in the Medical Specialties industry is in the same range as INFU (71). This means that PAVM’s stock grew similarly to INFU’s over the last 12 months.

PAVM's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as INFU (100). This means that PAVM’s stock grew similarly to INFU’s over the last 12 months.

INFU's SMR Rating (82) in the Medical Specialties industry is in the same range as PAVM (100). This means that INFU’s stock grew similarly to PAVM’s over the last 12 months.

INFU's Price Growth Rating (36) in the Medical Specialties industry is somewhat better than the same rating for PAVM (92). This means that INFU’s stock grew somewhat faster than PAVM’s over the last 12 months.

INFU's P/E Growth Rating (100) in the Medical Specialties industry is in the same range as PAVM (100). This means that INFU’s stock grew similarly to PAVM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
INFUPAVM
RSI
ODDS (%)
Bearish Trend 4 days ago
74%
Bullish Trend 4 days ago
77%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
83%
Bullish Trend 4 days ago
80%
Momentum
ODDS (%)
Bullish Trend 4 days ago
76%
Bearish Trend 4 days ago
84%
MACD
ODDS (%)
Bullish Trend 4 days ago
77%
Bearish Trend 4 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
70%
Bearish Trend 4 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
74%
Bearish Trend 4 days ago
89%
Advances
ODDS (%)
Bullish Trend 4 days ago
69%
N/A
Declines
ODDS (%)
Bearish Trend 19 days ago
79%
Bearish Trend 4 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
82%
Bullish Trend 4 days ago
84%
Aroon
ODDS (%)
Bullish Trend 4 days ago
62%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
INFU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PAVM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PHGUF1.16N/A
N/A
Pharming Group NV
RHCCF0.01N/A
N/A
Royal Helium Limited
HZRGF0.27N/A
N/A
HAZER GROUP LTD.
BXRBF6.30N/A
N/A
Bendigo & Adelaide Bank Ltd.
PSZKY21.90-0.60
-2.67%
Powszechna Kasa Oszczednosci Bank Polski SA

INFU and

Correlation & Price change

A.I.dvisor indicates that over the last year, INFU has been loosely correlated with NVST. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if INFU jumps, then NVST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INFU
1D Price
Change %
INFU100%
+1.05%
NVST - INFU
38%
Loosely correlated
-0.86%
QDEL - INFU
38%
Loosely correlated
-0.08%
TMCI - INFU
37%
Loosely correlated
-0.86%
RDNT - INFU
36%
Loosely correlated
-1.89%
IRMD - INFU
35%
Loosely correlated
+0.33%
More

PAVM and

Correlation & Price change

A.I.dvisor tells us that PAVM and SSII have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PAVM and SSII's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PAVM
1D Price
Change %
PAVM100%
-1.40%
SSII - PAVM
23%
Poorly correlated
-0.89%
BSGM - PAVM
22%
Poorly correlated
-2.55%
LUCD - PAVM
22%
Poorly correlated
+3.96%
NNOX - PAVM
21%
Poorly correlated
-1.78%
INFU - PAVM
21%
Poorly correlated
+1.05%
More